Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;60(8):1181-1183.
doi: 10.1038/s41409-025-02624-z. Epub 2025 May 13.

Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab

Carmine Liberatore  1   2 , Mario D'Uva  3   4 , Annalisa Natale  4 , Francesco Guardalupi  3 , Lucia Di Re  3 , Francesca Fioritoni  4 , Stefano Pulini  4 , Raffaele Spadano  4 , Doriana Vaddinelli  4 , Stella Santarone  4 , Mauro Di Ianni  3   4
Affiliations

Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab

Carmine Liberatore et al. Bone Marrow Transplant. 2025 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Peggs KS, Verfuerth S, Pizzey A, Khan N, Moss P, Goldstone AH, et al. Reconstitution of T-cell repertoire after autologous stem cell transplantation: Influence of CD34 selection and cytomegalovirus infection. Biol Blood Marrow Transpl. 2003;9:198–205.
    1. Kim JH, Goulston C, Sanders S, Lampas M, Zangari M, Tricot G, et al. Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation. Biol Blood Marrow Transpl. 2012;18:1753–8.
    1. Massoud R, Assi R, Fares E, Haffar B, Charafeddine M, Kreidieh N, et al. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation. J Clin Virol. 2017;95:36–41. - PubMed
    1. Marchesi F, Pimpinelli F, Ensoli F, Mengarelli A. Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematol Oncol. 2018;36:381–91. - PubMed
    1. Marchesi F, Mengarelli A, Giannotti F, Tendas A, Anaclerico B, Porrini R, et al. High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: A survey from the Rome Transplant Network. Transpl Infect Dis. 2014;16:158–64. - PubMed

LinkOut - more resources